Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 442

1.

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.

Pearson T, Caporaso JG, Yellowhair M, Bokulich NA, Padi M, Roe DJ, Wertheim BC, Linhart M, Martinez JA, Bilagody C, Hornstra H, Alberts DS, Lance P, Thompson PA.

Cancer Med. 2019 Jan 16. doi: 10.1002/cam4.1965. [Epub ahead of print]

2.

Finding the Responders in the Cancer Prevention Trials.

Thompson PA.

J Natl Cancer Inst. 2019 Jan 8. doi: 10.1093/jnci/djy205. [Epub ahead of print] No abstract available.

PMID:
30624679
3.

Fish Oil and Perioperative Bleeding.

Akintoye E, Sethi P, Harris WS, Thompson PA, Marchioli R, Tavazzi L, Latini R, Pretorius M, Brown NJ, Libby P, Mozaffarian D.

Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004584. doi: 10.1161/CIRCOUTCOMES.118.004584.

PMID:
30571332
4.

The understanding of complex syntax in children with Down syndrome.

Frizelle P, Thompson PA, Duta M, Bishop DVM.

Wellcome Open Res. 2018 Nov 1;3:140. doi: 10.12688/wellcomeopenres.14861.1. eCollection 2018.

5.

Uncertainties associated with assessing Ontario uranium miners' exposure to radon daughters.

Navaranjan G, Chambers D, Thompson PA, Do M, Berriault C, Villeneuve PJ, Demers PA.

J Radiol Prot. 2018 Nov 19;39(1):136-149. doi: 10.1088/1361-6498/aaf1eb. [Epub ahead of print]

PMID:
30524032
6.

A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.

Foster JH, Thompson PA, Bernhardt MB, Margolin JF, Hilsenbeck SG, Jo E, Marquez-Do DA, Scheurer ME, Schafer ES.

Cancer Chemother Pharmacol. 2018 Nov 28. doi: 10.1007/s00280-018-3733-2. [Epub ahead of print]

PMID:
30488179
7.

Stage 2 Registered Report: Variation in neurodevelopmental outcomes in children with sex chromosome trisomies: testing the double hit hypothesis.

Newbury DF, Simpson NH, Thompson PA, Bishop DVM.

Version 2. Wellcome Open Res. 2018 Oct 10 [revised 2018 Jan 1];3:85. doi: 10.12688/wellcomeopenres.14677.2. eCollection 2018.

8.

2018 Scholar's Research Symposium Abstracts.

Zeigler CN, Aaker B, Thompson PA, Kosmenko V.

S D Med. 2018 Sep;71(9):389. No abstract available.

PMID:
30308119
9.

Global patterns of change and variation in sea surface temperature and chlorophyll a.

Dunstan PK, Foster SD, King E, Risbey J, O'Kane TJ, Monselesan D, Hobday AJ, Hartog JR, Thompson PA.

Sci Rep. 2018 Oct 2;8(1):14624. doi: 10.1038/s41598-018-33057-y.

10.

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.

Chen LS, Bose P, Cruz ND, Jiang Y, Wu Q, Thompson PA, Feng S, Kroll MH, Qiao W, Huang X, Jain N, Wierda WG, Keating MJ, Gandhi V.

Blood. 2018 Nov 22;132(21):2249-2259. doi: 10.1182/blood-2018-06-860593. Epub 2018 Sep 25.

PMID:
30254130
11.

Shortened Taper Duration after Implementation of a Standardized Protocol for Iatrogenic Benzodiazepine and Opioid Withdrawal in Pediatric Patients: Results of a Cohort Study.

Vipond JM, Heiberger AL, Thompson PA, Huber JN.

Pediatr Qual Saf. 2018 May 18;3(3):e079. doi: 10.1097/pq9.0000000000000079. eCollection 2018 May-Jun.

12.

Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas.

Advani P, Bondy M, Thompson PA, Martínez ME, Nodora JN, Vernon SW, Diamond P, Burnett J, Brewster AM.

J Cancer Surviv. 2018 Oct;12(5):659-668. doi: 10.1007/s11764-018-0703-y. Epub 2018 Jul 25.

PMID:
30043339
13.

Point: Does Chemoimmunotherapy Still Have a Role in CLL? Chemoimmunotherapy With FCR Is Still an Important Option in CLL.

Thompson PA, Tam CS.

Oncology (Williston Park). 2018 Jun;32(6):291-2, 294-6. No abstract available.

14.

Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.

Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli A.

Leuk Lymphoma. 2018 Jun 18:1-3. doi: 10.1080/10428194.2018.1474527. [Epub ahead of print] No abstract available.

PMID:
29911929
15.

Growth in syntactic complexity between four years and adulthood: evidence from a narrative task.

Frizelle P, Thompson PA, McDonald D, Bishop DVM.

J Child Lang. 2018 Sep;45(5):1174-1197. doi: 10.1017/S0305000918000144. Epub 2018 Jun 4.

PMID:
29860949
16.

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies.

Thompson PA, Peterson CB, Strati P, Jorgensen J, Keating MJ, O'Brien SM, Ferrajoli A, Burger JA, Estrov Z, Jain N, Kadia TM, Borthakur G, DiNardo CD, Daver N, Jabbour E, Wierda WG.

Leukemia. 2018 Nov;32(11):2388-2398. doi: 10.1038/s41375-018-0132-y. Epub 2018 Apr 17.

17.

Stage 1 Registered Report: Variation in neurodevelopmental outcomes in children with sex chromosome trisomies: protocol for a test of the double hit hypothesis.

Newbury DF, Simpson NH, Thompson PA, Bishop DVM.

Wellcome Open Res. 2018 Feb 12;3:10. doi: 10.12688/wellcomeopenres.13828.2. eCollection 2018.

18.

Celecoxib use and circulating oxylipins in a colon polyp prevention trial.

Martinez JA, Yang J, Wertheim BC, Roe DJ, Schriewer A, Lance P, Alberts DS, Hammock BD, Thompson PA.

PLoS One. 2018 Apr 26;13(4):e0196398. doi: 10.1371/journal.pone.0196398. eCollection 2018.

19.

Interdisciplinary knowledge exchange across scales in a globally changing marine environment.

McDonald KS, Hobday AJ, Fulton EA, Thompson PA.

Glob Chang Biol. 2018 Jul;24(7):3039-3054. doi: 10.1111/gcb.14168. Epub 2018 May 24. Review.

PMID:
29656423
20.

Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI.

Ding J, Stopeck AT, Gao Y, Marron MT, Wertheim BC, Altbach MI, Galons JP, Roe DJ, Wang F, Maskarinec G, Thomson CA, Thompson PA, Huang C.

J Magn Reson Imaging. 2018 Oct;48(4):971-981. doi: 10.1002/jmri.26041. Epub 2018 Apr 6.

PMID:
29630755
21.

Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

Reich SH, Sprengeler PA, Chiang GG, Appleman JR, Chen J, Clarine J, Eam B, Ernst JT, Han Q, Goel VK, Han EZR, Huang V, Hung INJ, Jemison A, Jessen KA, Molter J, Murphy D, Neal M, Parker GS, Shaghafi M, Sperry S, Staunton J, Stumpf CR, Thompson PA, Tran C, Webber SE, Wegerski CJ, Zheng H, Webster KR.

J Med Chem. 2018 Apr 26;61(8):3516-3540. doi: 10.1021/acs.jmedchem.7b01795. Epub 2018 Mar 29.

PMID:
29526098
22.

MRD negativity as a surrogate for PFS in CLL?

Thompson PA.

Blood. 2018 Mar 1;131(9):943-944. doi: 10.1182/blood-2018-01-824177. No abstract available.

PMID:
29496697
23.

Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia.

Strati P, Ferrajoli A, Wierda WG, Jain N, Thompson PA, O'Brien SM, Rezvani K, Kantarjian HM, Burger JA, Hinojosa CO, Keating MJ, Estrov Z.

Leukemia. 2018 Oct;32(10):2278-2281. doi: 10.1038/s41375-018-0059-3. Epub 2018 Feb 20. No abstract available.

PMID:
29479067
24.

The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K.

Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017.

25.

Clinical factors associated with physician choice of femoral versus radial access: A real-world experience from a single academic center.

Yee J, Kumar V, Li S, Petraskova T, Pham A, Stys J, Thompson PA, Petrasko M, Stys A, Stys T.

J Interv Cardiol. 2018 Apr;31(2):236-243. doi: 10.1111/joic.12479. Epub 2017 Dec 25.

PMID:
29277921
26.

Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.

Jabbour E, Düll J, Yilmaz M, Khoury JD, Ravandi F, Jain N, Einsele H, Garcia-Manero G, Konopleva M, Short NJ, Thompson PA, Wierda W, Daver N, Cortes J, O'brien S, Kantarjian H, Topp MS.

Am J Hematol. 2018 Mar;93(3):371-374. doi: 10.1002/ajh.24987. Epub 2017 Dec 23.

PMID:
29178361
27.

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

Jain P, Nogueras González GM, Kanagal-Shamanna R, Rozovski U, Sarwari N, Tam C, Wierda WG, Thompson PA, Jain N, Luthra R, Quesada A, Sanchez-Petitto G, Ferrajoli A, Burger J, Kantarjian H, Cortes J, O'Brien S, Keating MJ, Estrov Z.

Br J Haematol. 2018 Jan;180(1):33-40. doi: 10.1111/bjh.15018. Epub 2017 Nov 21.

28.

Discussion of: "Pretransfer CT scans are frequently performed, but rarely helpful in rural trauma systems".

Thornburg DA, Paulson WE, Thompson PA, Bjordahl PM.

Am J Surg. 2017 Dec;214(6):1065-1066. doi: 10.1016/j.amjsurg.2017.10.007. Epub 2017 Oct 5. No abstract available.

PMID:
29145999
29.

Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL).

Thompson PA, Burger JA.

Expert Opin Investig Drugs. 2018 Jan;27(1):31-42. doi: 10.1080/13543784.2018.1404027. Epub 2017 Nov 15. Review.

PMID:
29125406
30.

Measuring language lateralisation with different language tasks: a systematic review.

Bradshaw AR, Thompson PA, Wilson AC, Bishop DVM, Woodhead ZVJ.

PeerJ. 2017 Oct 24;5:e3929. doi: 10.7717/peerj.3929. eCollection 2017.

31.

Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.

Khan M, Siddiqi R, Thompson PA.

Ann Hematol. 2018 Jan;97(1):1-15. doi: 10.1007/s00277-017-3149-9. Epub 2017 Oct 23. Review.

PMID:
29063177
32.

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.

Kondo K, Shaim H, Thompson PA, Burger JA, Keating M, Estrov Z, Harris D, Kim E, Ferrajoli A, Daher M, Basar R, Muftuoglu M, Imahashi N, Alsuliman A, Sobieski C, Gokdemir E, Wierda W, Jain N, Liu E, Shpall EJ, Rezvani K.

Leukemia. 2018 Apr;32(4):960-970. doi: 10.1038/leu.2017.304. Epub 2017 Oct 3.

PMID:
28972595
33.

Pretransfer CT scans are frequently performed, but rarely helpful in rural trauma systems.

Thornburg DA, Paulson WE, Thompson PA, Bjordahl PM.

Am J Surg. 2017 Dec;214(6):1061-1064. doi: 10.1016/j.amjsurg.2017.07.037. Epub 2017 Sep 18.

PMID:
28967379
34.

Logical and Methodological Issues Affecting Genetic Studies of Humans Reported in Top Neuroscience Journals.

Grabitz CR, Button KS, Munafò MR, Newbury DF, Pernet CR, Thompson PA, Bishop DVM.

J Cogn Neurosci. 2018 Jan;30(1):25-41. doi: 10.1162/jocn_a_01192. Epub 2017 Sep 26.

PMID:
28949821
35.

Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.

Tjarks BJ, Pownell BR, Evans C, Thompson PA, Kerkvliet AM, Koch MRD, Jassim AD.

J Cutan Pathol. 2018 Jan;45(1):1-7. doi: 10.1111/cup.13037. Epub 2017 Sep 19.

PMID:
28873247
36.

2017 Scholars Day Symposium Abstracts.

Thompson PA, Killian S, Kozmenko V, Zeigler CN.

S D Med. 2017 Sep;70(9):389. No abstract available.

PMID:
28863250
37.

2016 Scholars Day Symposium Abstracts.

Thompson PA, Killian S, Kozmenko V, Zeigler C.

S D Med. 2016 Sep;69(9):389. No abstract available.

PMID:
28806033
38.

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA.

Breast Cancer Res Treat. 2017 Aug;165(1):97-107. doi: 10.1007/s10549-017-4292-7. Epub 2017 May 30.

39.

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).

Jain P, Aoki E, Keating M, Wierda WG, O'Brien S, Gonzalez GN, Ferrajoli A, Jain N, Thompson PA, Jabbour E, Kanagal-Shamanna R, Pierce S, Alousi A, Hosing C, Khouri I, Estrov Z, Cortes J, Kantarjian H, Ravandi F, Kadia TM.

Ann Oncol. 2017 Jul 1;28(7):1554-1559. doi: 10.1093/annonc/mdx163.

40.

Phase 2 of CATALISE: a multinational and multidisciplinary Delphi consensus study of problems with language development: Terminology.

Bishop DVM, Snowling MJ, Thompson PA, Greenhalgh T; and the CATALISE-2 consortium.

J Child Psychol Psychiatry. 2017 Oct;58(10):1068-1080. doi: 10.1111/jcpp.12721. Epub 2017 Mar 30.

41.

Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.

Short NJ, Kantarjian HM, Ko H, Khoury JD, Ravandi F, Thomas DA, Garcia-Manero G, Khouri M, Cortes JE, Wierda WG, Verstovsek S, Estrov Z, Ferrajoli A, Thompson PA, Pierce S, O'Brien SM, Jabbour E.

Am J Hematol. 2017 Jun;92(6):E114-E117. doi: 10.1002/ajh.24720. Epub 2017 Apr 18. No abstract available.

42.

Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.

Thompson PA, Stingo F, Keating MJ, Wierda WG, O'Brien SM, Estrov Z, Ledesma C, Rezvani K, Qazilbash M, Shah N, Parmar S, Popat U, Anderlini P, Yago N, Ciurea SO, Kebriaei P, Champlin R, Shpall EJ, Hosing CM.

Br J Haematol. 2017 May;177(4):567-577. doi: 10.1111/bjh.14596. Epub 2017 Mar 14.

PMID:
28295181
43.

Analysis of Reimbursement of Genetic Counseling Services at a Single Institution in a State Requiring Licensure.

Leonhard JR, Munson PJ, Flanagan JD, De Berg KL, Thompson PA, Dean LW, Stein QP.

J Genet Couns. 2017 Aug;26(4):852-858. doi: 10.1007/s10897-016-0062-7. Epub 2017 Feb 8.

PMID:
28181058
44.

Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib.

Jain P, Thompson PA, Keating M, Estrov Z, Ferrajoli A, Jain N, Kantarjian H, Burger JA, O'Brien S, Wierda WG.

Cancer. 2017 Jun 15;123(12):2268-2273. doi: 10.1002/cncr.30596. Epub 2017 Feb 7.

45.

How I manage patients with hairy cell leukaemia.

Thompson PA, Ravandi F.

Br J Haematol. 2017 May;177(4):543-556. doi: 10.1111/bjh.14524. Epub 2017 Feb 1. Review.

PMID:
28146266
46.

Image-guided stereotactic radiosurgery for treatment of spinal hemangioblastoma.

Pan J, Ho AL, D'Astous M, Sussman ES, Thompson PA, Tayag AT, Pangilinan L, Soltys SG, Gibbs IC, Chang SD.

Neurosurg Focus. 2017 Jan;42(1):E12. doi: 10.3171/2016.10.FOCUS16361.

PMID:
28041328
47.

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium.

Balis FM, Thompson PA, Mosse YP, Blaney SM, Minard CG, Weigel BJ, Fox E.

Cancer Chemother Pharmacol. 2017 Jan;79(1):181-187. doi: 10.1007/s00280-016-3220-6. Epub 2016 Dec 28.

48.

Rising Incidence of Colorectal Cancer Among Young Hispanics in Texas.

Wang DY, Thrift AP, Zarrin-Khameh N, Wichmann A, Armstrong GN, Thompson PA, Bondy ML, Musher BL.

J Clin Gastroenterol. 2017 Jan;51(1):34-42.

49.

Physical Activity Modifies the Association between Dietary Protein and Lean Mass of Postmenopausal Women.

Martinez JA, Wertheim BC, Thomson CA, Bea JW, Wallace R, Allison M, Snetselaar L, Chen Z, Nassir R, Thompson PA.

J Acad Nutr Diet. 2017 Feb;117(2):192-203.e1. doi: 10.1016/j.jand.2016.10.009. Epub 2016 Nov 30.

50.

Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity.

Foster JH, Bernhardt MB, Thompson PA, Smith EO, Schafer ES.

J Pediatr Hematol Oncol. 2017 Jan;39(1):72-76.

PMID:
27820134

Supplemental Content

Loading ...
Support Center